Abstract
We evaluated isolates obtained from children with Mycoplasma pneumoniae infection throughout Japan during 2008-2015. The highest prevalence of macrolide-resistant M. pneumoniae was 81.6% in 2012, followed by 59.3% in 2014 and 43.6% in 2015. The prevalence of macrolide-resistant M. pneumoniae among children in Japan has decreased.
Keywords:
Japan; Mycoplasma pneumoniae; antimicrobial resistance; bacteria; children; drug resistance; macrolides; real-time PCR.
MeSH terms
-
Adolescent
-
Anti-Bacterial Agents / therapeutic use
-
Child
-
Child, Preschool
-
Drug Resistance, Bacterial / genetics*
-
Female
-
Humans
-
Infant
-
Infant, Newborn
-
Japan / epidemiology
-
Macrolides / therapeutic use*
-
Male
-
Microbial Sensitivity Tests
-
Mutation Rate
-
Mycoplasma pneumoniae / classification
-
Mycoplasma pneumoniae / drug effects
-
Mycoplasma pneumoniae / genetics*
-
Mycoplasma pneumoniae / isolation & purification
-
Pneumonia, Mycoplasma / drug therapy*
-
Pneumonia, Mycoplasma / epidemiology*
-
Pneumonia, Mycoplasma / microbiology
-
Prevalence
-
RNA, Ribosomal, 23S / genetics*
Substances
-
Anti-Bacterial Agents
-
Macrolides
-
RNA, Ribosomal, 23S